In this context, inorganic polyphosphates located in cells are recently emerging as a possible modulator of both tau aggregation and mitochondrial dysfunction, thereby contributing to the onset and progression of tauopathies, including Alzheimer's disease. The gene discussed is MAPT; the disease is Alzheimer disease.